Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Apo-Cabergoline Cabergoline 0.5mg Tablet Apotex NZ Limited Apotex Research Private Limited, Bangalore, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Celebrex Celecoxib 100mg Capsule Pfizer New Zealand Limited Neolpharma Inc, Caguas, Puerto Rico Pfizer Pharmaceuticals LLC, Vega Baja, Puerto Rico
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Celebrex Celecoxib 200mg Capsule Pfizer New Zealand Limited Neolpharma Inc, Caguas, Puerto Rico Pfizer Pharmaceuticals LLC, Vega Baja, Puerto Rico
|
Dated this 8th day of January 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).